Judith Smit is an entrepreneur who is driven to enable life science companies with strategic business- and financing support to ensure that more innovations reach society. She holds a PhD in Protein Crystallography from the Netherlands Cancer Institute and Erasmus MC, and she has dedicated the past 10 years of her career to the art of strategic fundraising and business plan optimization. She has raised over >€150M of funding for innovative companies in the MedTech, Therapeutics, Diagnostics and Digital Health. Since 6 years, she is the director and managing partner of FFUND BV, where she has joined forces with experienced biotech entrepreneurs to translate their knowledge into valuable revenue management support for life science companies. She has grown the FFUND team from 0 to 20+ people and is dedicated to become a pivotal European player to support start-ups and scale-ups to fast forward the development of innovations for the medical field.
FFUND is a boutique hands-on consulting company that is specialized in the Life Sciences. We offer expertise in acquiring and managing the full financing mix (incl. equity financing, grants, loans and tax credits) and provide Merger & Aquisition support for innovative companies.
FFUND was founded by a group of experienced biotech entrepreneurs with a common vision to accelerate the translation of innovation in the life science industry. Our mission is to leverage the expertise of experienced entrepreneurs with our team of 20+ consultants, to increase the number of successful exits and products on the market.
In the past years, we have served over 280 Life Science Start-ups, SMEs, and Universities in developing sharp business models and securing their strategic financing roadmap by shortening the time to money, optimize the position of the founding-team, and significantly increasing the overall chance of success.
Introduction to BioBusiness & Product
Development
Judith Smith's presentation on "Introduction to BioBusiness & Product Development" explores the challenging yet rewarding world of BioBusiness. This session aims to demystify the intricate landscape of BioBusiness, emphasizing the high-risk, capital-intensive nature of the industry and the substantial opportunities it presents. Participants will learn about the critical phases from scientific discovery to market launch, including key characteristics like high investment needs and prolonged timelines that typify the sector. Furthermore, the presentation outlines effective strategies for securing financing, managing intellectual property, and navigating regulatory landscapes to foster successful business ventures in life sciences. The session promises to equip attendees with the knowledge to discern why some startups in this innovative field succeed while others falter.
Powered by: BCF Courses BV | Connect with us | Join BioBusiness Summer School | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | REGISTER NOW |
© Copyright 2020 by BCF Courses